Nisa Investment Advisors LLC Purchases 3,680 Shares of DaVita Inc. (NYSE:DVA)

Nisa Investment Advisors LLC boosted its position in DaVita Inc. (NYSE:DVA) by 10.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 40,500 shares of the company’s stock after buying an additional 3,680 shares during the quarter. Nisa Investment Advisors LLC’s holdings in DaVita were worth $6,057,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the third quarter valued at approximately $25,000. Blue Trust Inc. lifted its position in DaVita by 56.4% during the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after buying an additional 119 shares in the last quarter. Quarry LP acquired a new position in shares of DaVita during the 3rd quarter worth about $60,000. Point72 Hong Kong Ltd bought a new position in shares of DaVita in the 2nd quarter valued at about $68,000. Finally, Versant Capital Management Inc increased its position in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares during the last quarter. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Performance

Shares of NYSE DVA opened at $170.06 on Friday. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. The company has a market capitalization of $13.94 billion, a P/E ratio of 18.35, a P/E/G ratio of 0.82 and a beta of 0.92. DaVita Inc. has a 12 month low of $104.70 and a 12 month high of $170.80. The stock has a 50 day moving average of $158.32 and a 200-day moving average of $153.80.

DaVita (NYSE:DVA) last released its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). The company had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. DaVita’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.85 earnings per share. As a group, equities research analysts predict that DaVita Inc. will post 9.71 EPS for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on DVA. Barclays raised their price target on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial raised their target price on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $161.80.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.